Article Details

SII's Phase 2/3 bridging trial results finally out, says Covishield comparable to AstraZeneca vaccine

Retrieved on: 2021-09-05 04:30:00

Tags for this article:

Click the tags to see associated articles and topics

SII's Phase 2/3 bridging trial results finally out, says Covishield comparable to AstraZeneca vaccine. View article details on hiswai:

Excerpt

Serum Institute of India's Covishield has a 'non-inferior' immune response compared to the Oxford AstraZeneca vaccine, says the pre-print paper of the ...

Article found on: www.nationalheraldindia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up